GlassScriptPhysician profile
Shital Rana
NPI 1265697015
$8,635.46
in general payments reported to CMS, 2019-2025
54 companies · $908 in 2025
The $908 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $1,335 · 2021: $1,492 · 2022: $1,244 · 2023: $1,160 · 2024: $1,196 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,171.90 | 2019-2025 | |
| Novo Nordisk INC | $1,067.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $695.12 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $672.71 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $598.90 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.36 | 2019-2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $287.97 | 2020-2024 | Trintellix |
| Amgen INC. | $275.88 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $269.64 | 2020-2025 | |
| Allergan, INC. | $261.77 | 2019-2020 | |
| Abbott Laboratories | $244.90 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $223.80 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $184.74 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $183.54 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Eisai INC. | $166.13 | 2019-2022 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shital Rana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.